Patents by Inventor Sylvie Chamoin

Sylvie Chamoin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aryl pyridine as aldosterone synthase inhibitors
    Patent number: 8519142
    Abstract: The present invention provides a compound of formula I; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: August 27, 2013
    Assignee: Novartis AG
    Inventors: Sylvie Chamoin, Qi-Ying Hu, Julien Papillon
  • IMIDAZOLE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS
    Publication number: 20130065893
    Abstract: The present invention provides a compound of formula (I) or pharmaceutically acceptable salt thereof, wherein the variables R1, R2, R3, R4, R5, R7 and p are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: November 29, 2010
    Publication date: March 14, 2013
    Applicant: NOVARTIS AG
    Inventors: Robert Sun, Lauren G. Monovich, Sylvie Chamoin, John Westbrook
  • Aryl pyridine as aldosterone synthase inhibitors
    Patent number: 8383827
    Abstract: The present invention provides a compound of formula I; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Grant
    Filed: May 14, 2010
    Date of Patent: February 26, 2013
    Assignee: Novartis AG
    Inventors: Sylvie Chamoin, Qi-Ying Hu, Julien Papillon
  • ARYL PYRIDINE AS ALDOSTERONE SYNTHASE INHIBITORS
    Publication number: 20130035354
    Abstract: The present invention provides a compound of formula I; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: September 14, 2012
    Publication date: February 7, 2013
    Applicant: NOVARTIS AG
    Inventors: Sylvie Chamoin, Qi-Ying Hu, Julien Papillon
  • ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS
    Publication number: 20120316195
    Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5 and n are defined herein. The invention also relates to a method for manufacturing compounds of the invention, and their therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: November 16, 2010
    Publication date: December 13, 2012
    Applicant: NOVARTIS AG
    Inventors: Martin Allan, Sylvie Chamoin, Qi-Ying Hu, Hidetomo Imase, Julien Papillon
  • 5-PYRIDIN-3-YL-1, 3-DIHYDRO-INDOL-2-ON DERIVATIVES AND THEIR USE AS MODULATORS OF ALDOSTERONE SYNTHASE AND/OR CYP11B1
    Publication number: 20120071512
    Abstract: The present invention provides a compound of formula I; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: May 12, 2010
    Publication date: March 22, 2012
    Applicant: NOVARTIS AG
    Inventors: Qi-Ying Hu, Sylvie Chamoin, Christopher M. Adams, Chun Zhang
  • ARYL PYRIDINE AS ALDOSTERONE SYNTHASE INHIBITORS
    Publication number: 20100292225
    Abstract: The present invention provides a compound of formula I; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: May 14, 2010
    Publication date: November 18, 2010
    Inventors: Sylvie Chamoin, Qi-Ying Hu, Julien Papillon
  • Substituted Dihydroimidazoles and their Use in the Treatment of Tumors
    Publication number: 20100075966
    Abstract: The invention relates to dihydroimidazoles of formula rac-(I), wherein the radicals and symbols are as defined herein; their use as inhibitors of the interaction of the MDM2 protein with a p53-like peptide, new pharmaceutical formulations comprising said compounds, said compounds for use in the therapeutic treatment of warm-blooded animals, especially humans, their use in the treatment of proliferative diseases or for the manufacture of pharmaceutical formulations useful in the treatment of proliferative diseases that respond to modulation of the interaction of the MDM2 protein with a p53-like peptide, a pharmaceutical formulation e.g. useful in the treatment of proliferative diseases that respond to modulation of the interaction of the MDM2 protein with a p53-like peptide comprising said compound, methods of treatment comprising administration of said compounds to a warm-blooded animal, and/or processes for the manufacture of said compounds.
    Type: Application
    Filed: November 26, 2007
    Publication date: March 25, 2010
    Inventors: Sylvie Chamoin, Hans- Jorg Roth, Juerg Zimmermann, Thomas Zoller
  • COMPOUNDS AND COMPOSITIONS AS LXR MODULATORS
    Publication number: 20090062260
    Abstract: The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of liver X receptors (LXRs).
    Type: Application
    Filed: November 14, 2006
    Publication date: March 5, 2009
    Applicants: IRM LLC, NOVARTIS AG
    Inventors: Valentina Molteni, David A. Ellis, Juliet Nabakka, Donatella Chianelli, Enrique Saez, Xiaolin Li, Sylvie Chamoin, Hans-Jorg Roth